Free Trial

Vera Therapeutics (VERA) Earnings Date, Estimates & Call Transcripts

Vera Therapeutics logo
$49.65 +0.10 (+0.20%)
(As of 11:57 AM ET)

Vera Therapeutics Latest Earnings Summary

Upcoming Q4
Earnings Date
Mar. 19Estimated
Actual EPS
(Nov. 7)
-$0.85 Missed By -$0.21
Consensus EPS
(Nov. 7)
-$0.64

Vera Therapeutics issued Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.85, which missed analysts' consensus estimates of -$0.64 by $0.21. With a trailing EPS of -$2.61, Vera Therapeutics' earnings are expected to decrease next year, from ($2.89) to ($3.28) per share.

VERA Upcoming Earnings

Vera Therapeutics' next earnings date is estimated for Wednesday, March 19, 2025, based off prior year's reporting schedules.

Get Vera Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vera Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

VERA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VERA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vera Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.61-$0.46-$0.54
Q2 20243-$0.65-$0.49-$0.57
Q3 20243-$0.67-$0.51-$0.59
Q4 20243-$0.75-$0.52-$0.64
FY 202411($2.68)($1.98)($2.33)

Vera Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/19/2025
(Estimated)
-------
11/7/2024Q3 2024-$0.64-$0.85 -$0.21-$0.85--
8/8/2024Q2 2024-$0.56-$0.62 -$0.06-$0.62--
5/9/2024Q1 2024-$0.53-$0.56 -$0.03-$0.56--
3/20/2024Q4 2023-$0.53-$0.58 -$0.05-$0.58--
11/9/2023Q3 2023-$0.50-$0.45+$0.05-$0.45--
8/10/2023Q2 2023-$0.69-$0.46+$0.23-$0.46--
5/11/2023Q1 2023-$0.59-$0.80 -$0.21-$0.80--
3/28/2023Q4 2022-$0.93-$1.19 -$0.26-$1.19--

Vera Therapeutics Earnings - Frequently Asked Questions

Vera Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates. Learn more on VERA's earnings history.

In the previous quarter, Vera Therapeutics (NASDAQ:VERA) missed the analysts' consensus estimate of ($0.64) by $0.21 with a reported earnings per share (EPS) of ($0.85). Learn more on analysts' earnings estimate vs. VERA's actual earnings.

Vera Therapeutics (NASDAQ:VERA) has a recorded net income of -$95.99 million. VERA has generated -$2.61 earnings per share over the last four quarters.

Vera Therapeutics's earnings are expected to decrease from ($2.89) per share to ($3.28) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:VERA) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners